Sponsor Pipeline

Supergene, LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
3
Phase 3
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT07324837
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within…		 Primary endpoint(s) modified
2026-07-24 NCT07324837
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within…		 Trial sites expanded: 15 -> 22 locations
Active Trials by Phase
Phase 3
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05372718 Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With… Acute Limb Ischemia Recruiting
NCT06362746 Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate… Pulmonary Embolism Recruiting
NCT07324837 Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within… Ischemic Stroke, Acute Recruiting
Not specified
NCT07245927 Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary… Pulmonary Embolism Acute Massive Recruiting
Disease Areas
Stroke (1)
Get alerts when Supergene, LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free